围术期阿司匹林使用与机器人肾部分切除术出血并发症相关
该多中心回顾性研究纳入5家高容量中心1565例行机器人肾部分切除术(RPN)患者,比较围术期继续服用阿司匹林81 mg(228例,14.5%)与未服用者的结局。结果显示pASA与围术期输血(11% vs 4%,p<0.001)和重大并发症(10% vs 3%,p<0.001)增加相关,多因素分析中pASA与输血风险升高独立相关(OR 1.94,95%CI 1.10-3.45)。作者认为在有经验的术者手中pASA使用合理且安全,但输血和重大并发症风险更高。
要点
- RPN围术期继续阿司匹林81 mg与输血率(11% vs 4%)和重大并发症(10% vs 3%)升高相关。
- 多因素分析显示pASA与输血风险独立相关(OR 1.94,95%CI 1.10-3.45)。
- 有经验的术者行RPN时pASA使用合理安全,但需警惕出血风险。
核心结论
- 在有经验的术者手中,RPN围术期继续阿司匹林81 mg是合理且安全的,但输血和重大并发症风险更高。
研究设计与样本
- 多中心回顾性评估5家高容量RPN中心行RPN的患者,比较围术期阿司匹林81 mg使用者与未使用者的围术期结局。
主要发现
- 1565例RPN患者中228例(14.5%)继续pASA,pASA组年龄更大(62.8 vs 56.8岁,p<0.001),Charlson评分更高(均值3 vs 2,p<0.001)。
- pASA与围术期输血增加相关(11% vs 4%,p<0.001)。
- pASA与重大并发症增加相关(10% vs 3%,p<0.001)。
- 多因素分析中pASA与输血风险升高相关(OR 1.94,95%CI 1.10-3.45)。
临床怎么用
- RPN术前对继续服用阿司匹林81 mg的患者应充分评估出血风险并做好输血准备。
- 对于需pASA进行心血管事件一级或二级预防的RPN患者,应与心内科协作权衡抗血小板治疗获益与出血风险。
局限性
- 回顾性研究设计,存在选择偏倚可能。
- pASA组患者年龄更大且Charlson评分更高,基线合并症更多可能影响结局比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Daily aspirin use following cardiovascular intervention is commonplace and creates concern regarding bleeding risk in patients undergoing surgery. Despite its cardio-protective role, aspirin is often discontinued 5-7 days prior to major surgery due to bleeding concerns. Single institution studies have investigated perioperative outcomes of aspirin use in robotic partial nephrectomy (RPN). We sought to evaluate the outcomes of perioperative aspirin (pASA) use during RPN in a multicenter setting. MATERIALS AND METHODS: We performed a retrospective evaluation of patients undergoing RPN at 5 high volume RPN institutions. We compared perioperative outcomes of patients taking pASA (81 mg) to those not on aspirin. We analyzed the association between pASA use and perioperative transfusion. RESULTS: Of 1,565 patients undergoing RPN, 228 (14.5%) patients continued pASA and were older (62.8 vs 56.8 years, p <0.001) with higher Charlson scores (mean 3 vs 2, p <0.001). pASA was associated with increased perioperative blood transfusions (11% vs 4%, p <0.001) and major complications (10% vs 3%, p <0.001). On multivariable analysis, pASA was associated with increased transfusion risk (OR 1.94, 1.10-3.45, 95% CI). CONCLUSIONS: In experienced hands, perioperative aspirin 81 mg use during RPN is reasonable and safe; however, there is a higher risk of blood transfusions and major complications. Future studies are needed to clarify the role of antiplatelet therapy in RPN patients requiring pASA for primary or secondary prevention of cardiovascular events.
引用
- Delto JC, Fleishman A, Chang P, et al. Perioperative Aspirin Use Is Associated with Bleeding Complications during Robotic Partial Nephrectomy. J Urol. 2021. PMID: 34555934. doi:10.1097/JU.0000000000002240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。